Patient/caregiver was educated on indications for Rosiglitazone use as follows:
Type 2 diabetes:
- Insulin is a hormone that helps with shifting the glucose in the blood into the cells of body tissues. This helps with regulating the blood sugar levels and providing nutrition to the cells of body tissues. Type-2 diabetes is a condition in which your body becomes resistant to the action insulin. Resistance to action of insulin hormone leads to poor shifting of glucose in the blood into the cells of body tissues. This leads to poor regulation of blood sugar levels with higher blood sugar numbers and poor nutrition supply to the cells of body tissues. Reduced nutrition supply to body tissues can contribute to diabetes symptoms, such as, feeling very tired, confusion, and blurred vision.
- Rosiglitazone acts by reducing insulin resistance and increasing the sensitivity of body cells to insulin. Improved/reduced insulin resistance by Rosiglitazone in Type 2 diabetes patients can contribute to increased response to insulin with improved shifting of glucose from the blood into the cells of body tissues. Increased glucose shifting into the cells leads to lowered blood sugar numbers and improved regulation of blood sugars. Increased glucose shifting into the cells contribute to better nutrition supply to the cells of body tissues. Improved nutrition supply to body tissues result in improvement in diabetes symptoms, such as, feeling very tired and confusion.
Type 1 diabetes
- Insulin is a hormone that helps with shifting the glucose in the blood into the cells of body tissues. This helps with regulating the blood sugar levels and providing nutrition to the cells of body tissues. Type-1 diabetes is a condition in which your immune system destroys the insulin producing cells in pancreas. This results in reduced or no insulin production by the body. Reduced or lack of insulin hormone leads to poor shifting of glucose in the blood into the cells of body tissues. This leads to poor regulation of blood sugar levels with higher blood sugar numbers and poor nutrition supply to the cells of body tissues. Reduced nutrition supply to body tissues can contribute to diabetes symptoms, such as, feeling very tired, confusion, and blurred vision.
- Rosiglitazone acts by reducing insulin resistance and increasing the sensitivity of body cells to insulin. Improved/reduced insulin resistance by Rosiglitazone in Type 1 diabetes patients can contribute to increased response to insulin with improved shifting of glucose from the blood into the cells of body tissues. Increased glucose shifting into the cells leads to lowered blood sugar numbers and improved regulation of blood sugars. Increased glucose shifting into the cells contribute to better nutrition supply to the cells of body tissues. Improved nutrition supply to body tissues result in improvement in diabetes symptoms, such as, feeling very tired and confusion. Type 1 diabetes patients with hardly any insulin secretion could be prescribed rosiglitazone as an adjunct to insulin therapy.
